|4A9H: N-Terminal Bromodomain Of Human Brd2 With 1-(2-Methyl-1,2,3, Tetrahydroquinolin-1-Yl)Ethan-1-One |
reference: Fragment-based discovery of bromodomain inhibitors part 1: inhibitor binding modes and implications for lead discovery., Chung CW, Dean TW, Woolven JM, Bamborough P, J Med Chem. 2011 Dec 5. PMID: 22136404
uses Jmol, developed by the Jmol Development Team (documentation).